CLINICAL AND BIOLOGICAL IMPACT OF TET2 MUTATIONS AND EXPRESSION IN YOUNGER ADULT AML PATIENTS TREATED WITHIN THE EORTC/GIMEMA AML-12 CLINICAL TRIAL.
Saved in:
| Title: | CLINICAL AND BIOLOGICAL IMPACT OF TET2 MUTATIONS AND EXPRESSION IN YOUNGER ADULT AML PATIENTS TREATED WITHIN THE EORTC/GIMEMA AML-12 CLINICAL TRIAL. |
|---|---|
| Authors: | Aslanyan, Mariam G.1, Kroeze, Leonie I.1, Langemeijer, Saskia M. C.1, Koorenhof-Scheele, Theresia N.1, Massop, Marion1, van Hoogen, Patricia1, Stevens-Linders, Ellen1, van de Locht, Louis T.1, Tönnissen, Evelyn1, van der Heijden, Adrian1, da Silva-Coelho, Pedro1,2, Cilloni, Daniela3, Saglio, Giuseppe3, Marie, Jean-Pierre4, Tang, Ruoping4, Labar, Boris5, Amadori, Sergio6, Muus, Petra7, Willemze, Roel2, Marijt, Erik W. A.2 |
| Source: | Romanian Journal of Oncology & Hematology. Dec2014, Vol. 2 Issue 4, p190-200. 9p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
